Forbes J A, Calderazzo J P, Bowser M W, Foor V M, Shackleford R W, Beaver W T
J Clin Pharmacol. 1982 Feb-Mar;22(2-3):89-96. doi: 10.1002/j.1552-4604.1982.tb02654.x.
Two-hundred and one outpatients with postoperative pain following oral surgery were randomly assigned, on a double-blind basis, a single oral dose of diflunisal (250, 500, or 1000 mg), aspirin (650 mg), or placebo. Using a self-rating record, the subjects rated their pain and its relief hourly for 12 hours after medication. Measures of peak and total analgesia were derived from the patients' subjective reports. Diflunisal 250 and 1000 mg were significantly superior to aspirin for every measure of total and peak analgesia; the 500-mg diflunisal dose was significantly superior to aspirin for measures of total analgesia only. All doses of diflunisal were significantly superior to aspirin and placebo at each hour from hour 3 through hour 12. Approximately 60 per cent of the patients treated with diflunisal completed the 12-hour observation period without the need for additional analgesic therapy. Adverse effects were mild and transitory and occurred in less than 10 per cent of the patients.
201例口腔外科术后疼痛的门诊患者被双盲随机分配,口服单次剂量的二氟尼柳(250毫克、500毫克或1000毫克)、阿司匹林(650毫克)或安慰剂。患者使用自评记录,在用药后12小时内每小时对疼痛及其缓解情况进行评分。峰值镇痛和总镇痛量由患者的主观报告得出。二氟尼柳250毫克和1000毫克在总镇痛和峰值镇痛的各项指标上均显著优于阿司匹林;500毫克二氟尼柳剂量仅在总镇痛指标上显著优于阿司匹林。从第3小时到第12小时的每个小时,所有剂量的二氟尼柳均显著优于阿司匹林和安慰剂。接受二氟尼柳治疗的患者中约60%完成了12小时的观察期,无需额外的镇痛治疗。不良反应轻微且短暂,不到10%的患者出现不良反应。